Anna Eshoo: “I think unless and until we acknowledge that, that we are really not being straight up.”

Thank you for holding the hearing, and I yield back.

I find it hypocritical when I hear time and time and time again that plans are often blocked by PBMs from offering the lowest-priced generic.

I see, as I expressed to you when we spoke, a disconnect between CMS, the FDA, and the VA on new treatments for mild Alzheimer's.

Spectrum is the gold in the 21st century. Nothing moves without spectrum.